Genesis Healthcare, Inc. (GENNQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 5, 2026
Genesis Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
Period Ending | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
| 3,906 | 4,566 | 4,977 | 5,374 | 5,625 | |
Revenue Growth (YoY) | -14.45% | -8.25% | -7.39% | -4.46% | 1.92% |
Cost of Revenue | 2,256 | 2,485 | 2,787 | 3,037 | 3,370 |
Gross Profit | 1,650 | 2,081 | 2,190 | 2,337 | 2,255 |
Selling, General & Admin | 594.51 | 593.67 | 279.04 | 315.24 | 332.31 |
Other Operating Expenses | 1,217 | 1,313 | 1,480 | 1,583 | 1,414 |
Operating Expenses | 1,920 | 2,030 | 1,980 | 2,245 | 2,000 |
Operating Income | -269.78 | 51.28 | 209.93 | 91.87 | 254.5 |
Interest Expense | -135.44 | -180.39 | -463.74 | -499.38 | -528.54 |
Interest & Investment Income | 3.99 | 7.3 | 6.83 | 5.33 | 3.02 |
Earnings From Equity Investments | 8.17 | 0.71 | 0.1 | 0.24 | 3.29 |
Other Non Operating Income (Expenses) | - | - | - | -4.06 | - |
EBT Excluding Unusual Items | -393.06 | -121.1 | -246.88 | -406.01 | -267.74 |
Merger & Restructuring Charges | -16.67 | -13 | -21.46 | -12.94 | - |
Impairment of Goodwill | - | - | - | -351.47 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | 3.91 |
Gain (Loss) on Sale of Assets | 120.36 | 90.72 | - | -0.42 | 198.16 |
Asset Writedown | -179 | -16.94 | -108.54 | -199.95 | -35.43 |
Legal Settlements | - | - | - | - | -15.19 |
Other Unusual Items | 361.4 | 69.54 | 2.04 | 1.19 | -19.22 |
Pretax Income | -106.98 | 9.23 | -374.84 | -969.6 | -135.51 |
Income Tax Expense | -3.61 | 1.75 | -2.42 | -10.43 | -17.44 |
Earnings From Continuing Operations | -103.37 | 7.47 | -372.42 | -959.17 | -118.08 |
Earnings From Discontinued Operations | - | - | - | -0.03 | 0.03 |
Net Income to Company | -103.37 | 7.47 | -372.42 | -959.2 | -118.05 |
Minority Interest in Earnings | 44.4 | 7.15 | 137.19 | 380.22 | 54.04 |
Net Income | -58.96 | 14.62 | -235.23 | -578.98 | -64.01 |
Net Income to Common | -58.96 | 14.62 | -235.23 | -578.98 | -64.01 |
Shares Outstanding (Basic) | 112 | 107 | 101 | 94 | 90 |
Shares Outstanding (Diluted) | 112 | 165 | 101 | 94 | 153 |
Shares Change (YoY) | -32.34% | 63.67% | 7.21% | -38.23% | 77.87% |
EPS (Basic) | -0.53 | 0.14 | -2.33 | -6.15 | -0.71 |
EPS (Diluted) | -0.53 | 0.10 | -2.33 | -6.15 | -0.82 |
Free Cash Flow | 52.8 | -661.55 | -32.57 | 56.35 | -24.76 |
Free Cash Flow Per Share | 0.47 | -4.00 | -0.32 | 0.60 | -0.16 |
Gross Margin | 42.24% | 45.57% | 44.00% | 43.49% | 40.09% |
Operating Margin | -6.91% | 1.12% | 4.22% | 1.71% | 4.52% |
Profit Margin | -1.51% | 0.32% | -4.73% | -10.77% | -1.14% |
Free Cash Flow Margin | 1.35% | -14.49% | -0.65% | 1.05% | -0.44% |
EBITDA | -161.94 | 174.44 | 407.72 | 345.05 | 517.06 |
EBITDA Margin | -4.15% | 3.82% | 8.19% | 6.42% | 9.19% |
D&A For EBITDA | 107.83 | 123.16 | 197.8 | 253.19 | 262.56 |
EBIT | -269.78 | 51.28 | 209.93 | 91.87 | 254.5 |
EBIT Margin | -6.91% | 1.12% | 4.22% | 1.71% | 4.52% |
Effective Tax Rate | - | 19.01% | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.